FDA Investigator Jay M Patria
Jay M Patria has conducted inspections on 70 sites in 1 countries as of 24 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
70
Last Inspection Date:
24 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jay M Patria:
Aldo J Quintana,
Alfred P Pistorio,
Alice C Silva,
Alois P Provost,
Alysia M Salonia,
Amber G Wardwell,
Andrew M Barlow,
Anne E Carpenter,
Anthony P Costello,
Ashley M Whitehurst,
Atricia L Irons,
Barbara G Swan,
Bradford L Swanson,
Brenda P King,
Carla C Tuite,
Christine L Williams,
Christopher A Demitrius,
Christopher K Vantwuyver,
Christopher M Elliott,
Darin S Wiegers,
Daryl A Dewoskin,
Dawn M Braswell,
Diantha M Turner,
Donahue,
Dorothy W Lee,
Douglas S Joslin,
Eduardo L Rodriguez,
Emily J Schramm,
Erich P Garger,
Frank J Koch,
Frank J Mazzoni,
Gerard D Difiore,
Hien Albright,
James K Mcnally,
Jamie S Mathews,
Janete F Guardia,
Janis S Gallagher,
Jason D Tenney,
Jeffery A Hangartner,
Jeffrey R Alling,
Jeffrey S Buckser,
Jessica D Spellman,
John A Hollings,
John L Zaccone,
John P Shelton,
Joppie,
Joseph B Cascio,
Joseph Foley,
Joseph H Procopio, Jr,
Joseph T Frost,
Joshua L Gibbs,
Joyce A Kellett,
Joyce A Williams,
Karen N Archdeacon,
Kathleen A Sousa,
Kathleen M Curry,
Lauren M Lawrance,
Laurie B Frazier,
LCDR Debra Emerson,
Liz M Otero,
Lorayne A Mcguinness,
Louis Christy,
Marcia M Laughrey,
Mark E Farrell,
Martin J Guardia,
Maryam Tabatabaie,
Mclaughlin,
Megan A Haggerty,
Michael J Pasternak,
Michelle M Noe Varga,
Mikayla K Deardorff,
Milan S Mcgorty,
Nasser Yazdani, DVM, MPH,
Nicholas J Scire,
Nichole B Murphy,
Osama A Khatib,
Pamela L Ogonowski,
Paraluman S Leonin,
Patricia A Homola,
Peter N Koufopoulos,
Ramcharan S Khalsa,
Rebecca A Coleman,
Rebecca B Welch,
Richard F Hapke,
Richard H Penta,
Richard L Licari,
Robert D Ogan,
Robert J Martin,
Rosa M Santiago,
Rupa Pradhan,
Sean M Tessicini,
Shawn M Bogdan,
Slater K Bartlett,
Stephanie J Cole,
Stephanie M Roberts Pedotti,
Stephen C King,
Steven M Ferrara,
Teddy Tom,
Thomas Cote,
Thomas H Jenkins,
Thomas J Kelly,
Thomas J Murphy,
Thomas Siebertz,
Thomas W Nerney,
Timothy M Glod,
Torrance J Slayton,
Troy R Petrillo,
Victoria Taylor,
Wendy A Johnecheck,
William K Dagley,
Zhong Y Wu
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more